GrowthCap

When it comes to building a company workforce, it should be all about skills, not job titles. Cue SkyHive by Cornerstone, a company founded in 2017 that applies artificial intelligence to workforce processes in innovative ways. Currently working with over 50 Fortune 100 companies including Deutsche Bank, Accenture, Best Buy, Merck, and more, SkyHive allows companies to build their teams based on cumulative skills rather than simplified work experience descriptions. It does this, in part, by accessing AI-charged, comprehensive profiles that a resume couldn't begin to capture. Since founding the company with ethical hiring in mind, 🍀Sean Hinton says that SkyHive's tech can fill critical company skill gaps while encouraging equitable hiring processes. AI is changing the future of work, and companies like SkyHive are pointing it in a conscientious direction. Listen on iTunes: https://lnkd.in/gFh8HHwM Listen on YouTube: https://lnkd.in/gnBUPkiJ Listen on Spotify: https://lnkd.in/ggwud422 Visit our website: https://lnkd.in/gUPeYy_Z Sign up for GrowthCap’s email newsletter https://lnkd.in/gXXniHP Nominate Top Software Investors of 2024 at https://lnkd.in/g9hfKiYb #hiring #workforce #labor #AI #machinelearning #podcast

Leading Healthcare Investor: Advent International’s Carmine Petrone speaks with RJ Lumba Carmine Petrone, a Managing Director at Advent International, one of the largest and most experienced global private equity investors with over $94 billion in assets under management. Carmine joined Advent in 2010 and focuses on making investments in the healthcare and healthcare technology sectors. Prior to Advent, he worked for Thomas H. Lee Partners, where he was a generalist investor with a focus on leveraged buyouts in the financial and business services and healthcare industries. Carmine has also spent time working in the hedge fund industry. He started his career in investment banking with Citigroup Global Markets where he was a member of the Global Health Care team. Listen on iTunes: https://lnkd.in/gQtiaheN Listen on YouTube: https://lnkd.in/gYEf-uUa Listen on Spotify: https://lnkd.in/gW9AutwT Visit our website: https://lnkd.in/g-TDtmM2 Sign up for GrowthCap’s email newsletter https://lnkd.in/gXXniHP Nominate Top Software Investors of 2024 at https://lnkd.in/g9hfKiYb #leadership #investing #technology #healthtech #healthcare #privateequity

osapiens receives $120 million in funding from Goldman Sachs Alternatives and Armira. osapiens develops holistic Software-as-a-Service solutions that enable global companies from a wide range of industries to ensure transparency, efficiency and trust along their entire value chain. Sign up for GrowthCap’s email newsletter https://lnkd.in/gXXniHP Nominate Top Software Investors of 2024 at https://lnkd.in/g9hfKiYb #software #saas #venturecapital

Altana receives $200 million in funding from US Innovative Technology Fund, Salesforce Ventures, OMERS Ventures, March Capital, GV (Google Ventures), Generation Investment Management, Friends & Family Capital, Floating Point, and Activate Capital Partners. Altana Technologies transforms the world’s public and non-public data into an intelligent, shared map of the global supply chain. Sign up for GrowthCap’s email newsletter https://lnkd.in/gXXniHP Nominate Top Software Investors of 2024 at https://lnkd.in/g9hfKiYb #software #saas #venturecapital #supplychain

CV3 Financial Services receives $100 million in debt funding. CV3 Financial Services is a private lender providing business purpose loans for non-owner-occupied properties to real estate investors. Sign up for GrowthCap’s email newsletter https://lnkd.in/gXXniHP Nominate Top Software Investors of 2024 at https://lnkd.in/g9hfKiYb #fintech #financialservices #venturecapital #lending

Vanta receives $150 million in funding from Y Combinator, Workday Ventures, Sequoia Capital, JPMorganChase, HubSpot Ventures, Goldman Sachs Alternatives, CrowdStrike, Craft Ventures, and Atlassian Ventures. Vanta is an automated security monitoring platform that helps companies get SOC 2, HIPAA, or ISO 27001 certified quickly. Sign up for GrowthCap’s email newsletter https://lnkd.in/gXXniHP Nominate Top Software Investors of 2024 at https://lnkd.in/g9hfKiYb #software #saas #venturecapital #cybersecurity

Pathfinder receives $325 million in debt funding from Silver Rock Group. Pathfinder is an information technology company that provides AI-based retail intelligence solutions for brands and companies. Sign up for GrowthCap’s email newsletter https://lnkd.in/gXXniHP Nominate Top Software Investors of 2024 at https://lnkd.in/g9hfKiYb #software #saas #venturecapital #artificialintelligence

Autobahn Therapeutics, Inc. receives $100 million in funding from Section 32, Samsara BioCapital, Pfizer Venture Investments, Newpath Management, Monograph Capital, Invus, Insight Partners, GT Healthcare Capital Partners, Canaan Partners, BVF Partners, Bristol Myers Squibb, Blue Owl, Biogen, ARCH Venture Partners, and Alexandria Venture Investments. Autobahn Therapeutics is a biotechnology company developing a portfolio of neuropsychiatric and neuroimmunologic clinical candidates leveraging its brain-targeting chemistry platform. Sign up for GrowthCap’s email newsletter https://lnkd.in/gXXniHP Nominate Top Software Investors of 2024 at https://lnkd.in/g9hfKiYb #healthtech #healthcare #biotechnology #venturecapital

Clio - Cloud-Based Legal Technology receives $900 million in funding from T. Rowe Price, Tidemark, TCV, Sixth Street, OMERS Private Equity, New Enterprise Associates (NEA), JMI Equity, Goldman Sachs Asset Management, and CapitalG. Clio is the world's leading provider of cloud-based legal technology, providing lawyers with low-barrier, affordable solutions to manage and grow their firms more effectively, more profitably, and with better client experiences. Sign up for GrowthCap’s email newsletter https://lnkd.in/gXXniHP Nominate Top Software Investors of 2024 at https://lnkd.in/g9hfKiYb #software #saas #venturecapital #legaltech

Third Arc Bio receives $165 million in funding from Vida Ventures, T. Rowe Price, Omega Funds, Marshall Wace, Logos Capital, Janus Henderson Investors, Hillhouse Investment, Goldman Sachs Alternatives, Freepoint Capital Group, Foresite Capital, Cormorant Asset Management, LP, BVF Partners, abrdn, and AbbVie Biotech Ventures. Third Arc Bio is a biotech company developing multifunctional antibodies for inflammatory and immunology diseases. Sign up for GrowthCap’s email newsletter https://lnkd.in/gXXniHP Nominate Top Software Investors of 2024 at https://lnkd.in/g9hfKiYb #healthtech #healthcare #venturecapital #biotechnology